While liver cancer is one of the most common forms of cancer the in the world, it is considerably less common in the United States. Because liver cancer most commonly presents itself in later stages, due to early stage symptoms that present as digestive health or gastrointestinal issues, it is often found at a more advanced state. Most often, liver cancer will require a combination of therapies, including surgery, chemotherapy and radiation therapy. Working with the dedicated multidisciplinary team at Florida Hospital Cancer Institute, the combination of therapies involved in your treatment planning will be designed and chosen with you depending on the stage of your cancer, your age and overall health, and other factors.
At the Florida Hospital Cancer Institute, we treat more newly diagnosed cancer patients that any facility in the country. We’ve assembled a team of some of the nation’s leading gastrointestinal and colorectal cancer experts from our Digesting Health Center and Gastrointestinal and Colorectal Cancer Program, including gastroenterologists, surgeons, medical oncologists, radiation oncologists, therapeutic endoscopists, radiologists and a dedicated gastrointestinal cancer care coordinator. These experts meet regularly and work closely together to devise individual treatment plans for individual cases.
The Florida Hospital Cancer Institute is accredited by several national cancer organizations for their quality, outcomes and comprehensive care. FHCI is accredited by the American College of Surgeons’ Commission on Cancer (COC) and the Quality Oncology Practice Initiative (QOPI). Most recently, our Clinical Research Center has been awarded a $2.1 million grant from the National Cancer Institute’s Community Clinical Oncology Program (CCOP), allowing FHCI access to NCI’s prevention, control and treatment trials for cancer treatment and prevention more about clinical trials or The Florida Hospital Liver Cancer Program.
Learn more about Florida Hospital Cancer Institute’s offerings: